Dose determination in rectum and urethra with TLD dosimeters in prostate brachytherapy with High Dose Rate (HDR)

被引：0
|
作者：
Gonzalez, J [1 ]
Rodriguez, A [1 ]
Crelgo, D [1 ]
Villacé, A [1 ]
Fernandez, P [1 ]
Sanchez, A [1 ]
Vivanco, J [1 ]
Sanz, D [1 ]
De la Ru, A [1 ]
Prada, P [1 ]
机构：
[1] Hosp Cent Asturias, Unidad Radiofis, Oviedo, Spain
来源：
RADIOTHERAPY AND ONCOLOGY | 2005年 / 76卷
关键词：
D O I：
10.1016/S0167-8140(05)81265-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [41] Previous Transurethral Resection of the Prostate (TURP) is Not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer
    Manning, M.
    Mark, R. J.
    Anderson, P. J.
    Akins, R. S.
    Nair, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S318 - S318
  • [42] Previous Transurethral Resection of the Prostate (TURP) is not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer
    Manning, M.
    Mark, R. J.
    Anderson, P. J.
    Akins, R. S.
    Nair, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S371 - S371
  • [43] PREVIOUS TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) IS NOT A CONTRAINDICATION FOR INTERSTITIAL HIGH DOSE RATE (HDR) BRACHYTHERAPY FOR PROSTATE CANCER
    Manning, S.
    Mark, R.
    Anderson, P.
    Akins, R.
    Nair, M.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S412 - S413
  • [44] Previous Transurethral Resection of the Prostate (TURP) is not a Contraindication for Interstitial High Dose Rate (HDR) Brachytherapy for Prostate Cancer
    Mark, R. J.
    White, D.
    Akins, R.
    Mutyala, S.
    Nair, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S386 - S387
  • [45] HEALTH RELATED QUALITY OF LIFE FOLLOWING HIGH DOSE-RATE BRACHYTHERAPY BOOST FOR PROSTATE CANCER: DOSE TO URETHRA MATTERS
    Morton, G.
    Oblaw, A. L.
    Chung, H.
    Deabreu, A.
    Zhang, L.
    Cheung, P.
    Danjoux, C.
    Szumacher, E.
    Vigneault, E.
    Springer, C.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S3 - S3
  • [46] High dose rate (HDR) prostate boost brachytherapy: A comparison of acute and chronic toxicities between three dose escalation groups
    Boyea, G
    Martinez, A
    Wallace, M
    Chen, P
    Gustafson, G
    Lewis, L
    Flynn, C
    Axiak, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S188 - S188
  • [47] PARAMETERS AFFECTING THE UNKNOWN RECTUM DOSE IN HDR BRACHYTHERAPY OF PROSTATE CANCER WHEN USING A PROSTATE DISPLACEMENT KIT
    Bo, B.
    Leite, C.
    Kofoed-Larsen, E.
    Hagen, K. Hammerfjell
    Folkedal
    Bergstrand, E. S.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S403 - S403
  • [48] To plan or not to plan: Multiple high dose rate (HDR) brachytherapy insertions
    Lowenstein, JR
    Roll, J
    Ibbott, GS
    MEDICAL PHYSICS, 2003, 30 (06) : 1464 - 1464
  • [49] Commissioning Integrated System in High-Dose-Rate (HDR) Brachytherapy
    Saw, C.
    Juliano, J.
    Wagner, H.
    MEDICAL PHYSICS, 2011, 38 (06) : 3516 - U64
  • [50] IS FOLEY CATHETER AN ADEQUATE SURROGATE FOR URETHRA WHEN PLANNING HIGH-DOSE RATE PROSTATE BRACHYTHERAPY?
    Tetreault-Laflamme, Audrey
    Araujo, Cynthia
    Bachand, Francois
    Schmid, Matthew
    Batchelar, Deidre
    Crook, Juanita
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S14 - S15
12345